The ability to command a room, have hushed conversations with loved ones, or even something as simple as answering the phone — these are all things Robin Leaper had to learn anew after amyotrophic ...

Australia’s Neurizon Therapeutics, a biotech advancing innovative treatments for neurodegenerative diseases, has reported positive top-line results from the Open-Label Extension (OLE) study of its ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

The long-term data supports the drug’s progression into the HEALEY ALS Platform trial, with NUZ-001 dosing set to commence in Q4 2025. This will only begin, however, if the US Food and Drug ...

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

A physical fitness challenge named the “Pete and Bobby Challenge” was held on the 19th at a massive gym facility in the U.S.

A strong performance from APA’s gas transmission and storage business contributed to a 6.4% lift in EBITDA for the company, ...

Brain-computer interfaces (BCIs) are emerging as a groundbreaking technology that has the potential to revolutionize the way humans interact with machines. By bridging the gap between human cognition ...

Texas senators approved several bills Monday, one of which included another attempt at blocking hemp-derived THC products.

The Driving and Vehicle Licensing Agency (DVLA) could slap drivers with a £1,000 fine if they fail to report certain health conditions to the motoring authority.